Schedule 13G ownership disclosure
MATEON THERAPEUTICS INC
Security class unavailable · CUSIP: 57667K109
Event date: 2018-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 879,747
- Percent of class
- 2.1200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001535610-19-000003
- Form type
- SC 13G
- Filer
- Oncotelic Therapeutics, Inc.
- CIK
- CIK 908259
- Filed
- Jan 02, 2019
- Reporting period
- Dec 31, 2018
- Description
- Schedule 13G beneficial ownership